Metlife Inc (MET): who owns it and who trades it
As of Nov 16, 2026, MET insiders reported 2 open-market sales worth $21M and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Michel Khalaf (CEO), with $19.3M. 9 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Metlife
From the latest filingsOverall: more selling than buying. Insiders mostly sold. Famous investors mostly bought. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns MET
1,437 funds and institutions reported MET shares worth $41.4B at the end of Q2 2026, about 76% of the company. The largest holder is BlackRock, Inc. with 8.0%.
Funds and institutions (13F) 76%Everyone else 24%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 51.79M | 8.05% | $4.4B | +1% |
| Dodge & Cox | 48.43M | 7.53% | $4.1B | -5% |
| Vanguard Capital Management LLC | 35.48M | 5.51% | $3B | -1% |
| Vanguard Portfolio Management LLC | 30.03M | 4.67% | $2.5B | -3% |
| State Street Corp | 25.34M | 3.94% | $2.1B | +0% |
| T. Rowe Price Associates | 21.28M | 3.31% | $1.8B | -7% |
| Geode Capital Management, LLC | 13.31M | 2.07% | $1.1B | +0% |
| Morgan Stanley | 12.53M | 1.95% | $1.1B | +13% |
| Pzena Investment Management LLC | 11.13M | 1.73% | $942M | -2% |
| Dimensional Fund Advisors LP | 7.19M | 1.12% | $608M | +1% |
| Invesco Ltd. | 6.93M | 1.08% | $586M | +0% |
| Norges Bank | 6.82M | 1.06% | $577M | – |
| Goldman Sachs Group Inc | 6.63M | 1.03% | $561M | +7% |
| Northern Trust Corp | 6.30M | 0.98% | $533M | -1% |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 6.03M | 0.94% | $510M | +6% |
| Arrowstreet Capital, Limited Partnership | 5.81M | 0.90% | $491M | +87% |
| Clearbridge Investments, LLC | 5.64M | 0.88% | $477M | +10% |
| Bank of America Corp | 5.38M | 0.84% | $455M | -2% |
| Nordea Investment Management AB | 5.04M | 0.78% | $429M | +5% |
| AQR Capital Management LLC | 4.12M | 0.64% | $349M | +13% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, MET insiders reported $0 of open-market purchases and $21M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 10, 2026 | Michel Khalaf | CEO | Sale | 187,425 | $102.97 | $19.3M | Form 4 |
| Jun 1, 2026 | Marlene Debel | Vice president | Sale | 21,312 | $81.59 | $1.7M | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Michel Khalaf | President & CEO, Director | – | $19.3M | Nov 10, 2026 |
| Marlene Debel | EVP & Chief Risk Officer | – | $1.7M | Jun 1, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
MET short interest
Low short interest. 1.7% of MET shares are sold short: about 1 share in 58. Over the last 12 reports the number of shares short went down 11%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 10.75M MET shares were sold short, 1.7% of the shares outstanding, down 0.1% from the report before. At the average daily volume of 3.13M shares, buying them all back would take about 3.4 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 10.75M | 1.71% | -0% | 3.13M | 3.4 |
| Oct 15, 2026 | 10.76M | 1.69% | -4% | 3.28M | 3.3 |
| Sep 30, 2026 | 11.20M | 1.76% | -9% | 3.37M | 3.3 |
| Sep 15, 2026 | 12.29M | 1.93% | +4% | 2.76M | 4.4 |
| Aug 31, 2026 | 11.85M | 1.87% | +5% | 2.94M | 4.0 |
| Aug 14, 2026 | 11.31M | 1.78% | +0% | 3.47M | 3.3 |
| Jul 31, 2026 | 11.29M | 1.78% | -12% | 4.41M | 2.6 |
| Jul 15, 2026 | 12.77M | 1.99% | -11% | 3.05M | 4.2 |
| Jun 30, 2026 | 14.29M | 2.22% | -10% | 4.58M | 3.1 |
| Jun 15, 2026 | 15.88M | 2.47% | +14% | 3.46M | 4.6 |
| May 29, 2026 | 13.99M | 2.17% | +16% | 3.74M | 3.7 |
| May 15, 2026 | 12.11M | 1.88% | -2% | 3.18M | 3.8 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Members of Congress who traded MET
Since Nov 17, 2024, 4 members of Congress reported 1 purchase and 3 sales of MET. The latest was a purchase by Alan Armstrong on Mar 27, 2026, reported Jul 21, 2026.
Purchases 1Sales 3
Reported trades
| Trade date | Member | Type | Amount | Owner | Reported | Source |
|---|---|---|---|---|---|---|
| Mar 27, 2026 | Alan Armstrong (R-OK) | Purchase | $1K–$15K | Self | Jul 21, 2026 | Report |
| Aug 6, 2025 | Gilbert Ray Cisneros, Jr. (D-CA) | Partial sale | $1K–$15K | Self | Sep 12, 2025 | Report |
| Jul 11, 2025 | Ritchie Torres (D-NY) | Sale | $1K–$15K | Self | Aug 20, 2025 | Report |
| Nov 19, 2024 | Sheldon Whitehouse (D-RI) | Sale | $1K–$15K | Spouse | Dec 5, 2024 | Report |
Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work
Metlife company events
Metlife filed 20 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Nov 10, 2026.
- Nov 10, 2026AgreementMetLife, Inc., a Delaware corporation, and MetLife Funding, Inc., a Delaware corporation and wholly-owned subsidiary of the Company (together with the Company, the “Borrowers”), amended and restated in its entirety their Amended and Restated Credit Agreement, dated as of May 8, 2023 (as amended and… Filing
- Nov 4, 2026AnnouncementThe text of Item 2.02 above with respect to the Total AUM Fact Sheet is incorporated herein by reference. 2 Item 9.01 Financial Statements and Exhibits. 99.1 Earnings Release dated November 4, 2026 99.2 Quarterly Financial Supplement for the quarter ended September 30, 2026 99.3 Total AUM Fact… Filing
- Sep 24, 2026AnnouncementShared information with investors. Filing
- Aug 17, 2026AnnouncementMetLife, Inc. issued a news release announcing the declaration of (i) a quarterly dividend of $0.31471411 per share on MetLife, Inc.’s floating rate non-cumulative preferred stock, Series A, $25 liquidation preference per share; (ii) a semi-annual dividend of $29.375 per share on MetLife, Inc.’s… Filing
- Aug 5, 2026AnnouncementMetLife, Inc. announced that its Board of Directors approved a new $3.0 billion authorization to repurchase its common stock. Filing
- Jun 29, 2026AnnouncementShared information with investors. Filing
- Jun 22, 2026VoteReported shareholder vote results. Filing
- May 15, 2026AnnouncementMetLife, Inc. issued a news release announcing the declaration of (i) a quarterly dividend of $0.31190376 per share on MetLife, Inc.’s floating rate non-cumulative preferred stock, Series A, $25 liquidation preference per share; (ii) a quarterly dividend of $351.5625 per share on MetLife, Inc.’s… Filing
- May 6, 2026AnnouncementThe text of Item 2.02 above with respect to the Total AUM Fact Sheet is incorporated herein by reference. 2 Item 9.01 Financial Statements and Exhibits. 99.1 Earnings Release dated May 6, 2026 99.2 Quarterly Financial Supplement for the quarter ended March 31, 2026 99.3 Total AUM Fact Sheet as of… Filing
- Apr 7, 2026AnnouncementShared information with investors. Filing
- Mar 5, 2026AnnouncementMetLife, Inc. issued a news release confirming its previously announced declaration of a first quarter 2026 dividend of $0.31501229 per share on MetLife, Inc.’s floating rate non-cumulative preferred stock, Series A, $25 liquidation preference per share. Filing
- Feb 26, 2026AnnouncementThe Company entered into (i) an underwriting agreement (attached hereto as Exhibit 1.1 and incorporated herein by reference) and (ii) a pricing agreement (attached hereto as Exhibit 1.2 and incorporated herein by reference) relating to the sale of the Debentures, each among the Company and Barclays… Filing
- Feb 24, 2026LeadershipThe Board of Directors of MetLife, Inc. increased the number of directors serving on the Board from eleven to thirteen, and elected Daniel S. Glaser and Michelle R. Seitz as directors of the Company. Filing
- Feb 17, 2026AnnouncementMetLife, Inc. issued a news release announcing the declaration of (i) a semi-annual dividend of $29.375 per share on MetLife, Inc.’s 5.875% fixed-to-floating rate non-cumulative preferred stock, Series D, $1,000 liquidation preference per share; (ii) a quarterly dividend of $351.5625 per share on… Filing
- Feb 4, 2026AnnouncementThe text of Item 2.02 above with respect to the Total AUM Fact Sheet is incorporated herein by reference. Filing
- Jan 9, 2026AnnouncementShared information with investors. Filing
- Dec 30, 2025AnnouncementMetLife, Inc. issued a fact sheet setting forth the pro forma combined total assets under management of MetLife Investment Management and PineBridge, as if the Acquisition had occurred as of September 30, 2025, a copy of which is attached hereto as Exhibit 99.2 and is incorporated herein by… Filing
- Dec 22, 2025AnnouncementShared information with investors. Filing
- Dec 1, 2025AnnouncementShared information with investors. Filing
- Nov 17, 2025AnnouncementMetLife, Inc. issued a news release announcing the declaration of (i) a quarterly dividend of $0.33489390 per share on MetLife, Inc.’s floating rate non-cumulative preferred stock, Series A, $25 liquidation preference per share; (ii) a quarterly dividend of $351.5625 per share on MetLife, Inc.’s… Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Metlife financials
Famous investors that hold MET
9 of the 50 well-known investors we track reported holding MET in their latest 13F filing. The largest position is Richard Pzena's, worth $995M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Richard Pzena · Pzena Investment Management | Q3 2026 | 10.57M | $995M | 2.9% | -5% |
| Ray Dalio · Bridgewater Associates | Q3 2026 | 704,695 | $66.4M | 0.3% | +13% |
| Israel Englander · Millennium Management | Q3 2026 | 329,403 | $31M | 0.0% | +75% |
| Paul Tudor Jones · Tudor Investment Corp | Q3 2026 | 261,778 | $24.6M | 0.1% | New |
| Ken Griffin · Citadel Advisors | Q3 2026 | 167,003 | $15.7M | 0.0% | -81% |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 84,300 | $7.9M | 0.0% | New |
| Jeremy Grantham · GMO | Q3 2026 | 71,193 | $6.7M | 0.0% | -15% |
| Lee Ainslie · Maverick Capital | Q3 2026 | 19,934 | $1.9M | 0.0% | New |
| Ken Fisher · Fisher Asset Management | Q3 2026 | 5,465 | $515K | 0.0% | -0% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named MET in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 12, 2026 | Dodge & Cox | 13G/A | 5.3% |
| Nov 12, 2026 | Dodge & Cox | 13G/A | 5.3% |
| Nov 5, 2026 | Board of Directors of MetLife, Inc., as an entity | 13D/A | 16.0% |
| Nov 5, 2026 | Board of Directors of MetLife, Inc., as an entity | 13D/A | 16.0% |
Questions about Metlife Inc (MET) stock
Who owns the most MET stock?
The largest reported owner of Metlife Inc (MET) is BlackRock, Inc., with 8.0% of the company. In total, 1,437 funds and institutions reported holding MET at the end of Q2 2026, together about 76% of the shares. See the largest owners.
Are MET insiders buying or selling?
In the last 12 months, MET insiders reported no open-market purchases and 2 sales worth $21M. The latest trade was on Nov 10, 2026. See every trade.
What is the short interest in MET?
As of Oct 30, 2026, 10.75M MET shares were sold short, 1.7% of the shares outstanding, down 0.1% from the report before. At the average daily volume of 3.13M shares, buying them all back would take about 3.4 trading days (days to cover). See the history.
Have members of Congress traded MET?
Yes. 4 members of Congress reported 1 purchase and 3 sales of MET since Nov 17, 2024. The latest was reported on Jul 21, 2026. See the trades.
Which famous investors hold MET?
9 of the 50 well-known investors we track reported MET in their latest 13F filing, including Richard Pzena, Ray Dalio, Israel Englander. The largest position is worth $995M. See all holders.
Executive pay
Metlife's chief executive was paid a total of $22.4M for the year ended Dec 31, 2025, up 10% from $20.3M the year before. In the last 12 months, Metlife's executives and directors bought no stock on the open market and sold $21M.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.